Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seymour Diamond

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Physician and Sportsmedicine|December 28, 2017
Treating Athletes Who Have Posttraumatic HeadachesSeymour Diamond
CNS Drugs|May 25, 2002
Practical approaches to migraine managementSeymour Diamond, Richard Wenzel
Postgraduate Medicine|July 15, 2016
Editor's MailSeymour Diamond, Charles B Fernandes, Arnold Potek
Headache|May 13, 2008
American headache through the decades: 1950 to 2008Seymour Solomon, Seymour Diamond, Ninan Mathew, et al.
Headache|November 29, 2007
Botulinum Toxin Type A in the treatment of chronic migraine without medication overuseFrederick G Freitag, Seymour Diamond, Merle Diamond, et al.
The Journal of Headache and Pain|January 16, 2007
Sumatriptan 6 mg subcutaneous as an effective migraine treatment in patients with cutaneous allodynia who historically fail to respond to oral triptansSeymour Diamond, Fred G Freitag, Alexander Feoktistov, et al.
Pharmacotherapy|May 28, 2004
Migraine headache misconceptions: barriers to effective careRichard Wenzel, Marcus Dortch, Roger Cady, et al.
Headache|June 24, 2008
Efficacy and tolerability of coadministration of rizatriptan and acetaminophen vs rizatriptan or acetaminophen alone for acute migraine treatmentFred Freitag, Merle Diamond, Seymour Diamond, et al.
Pharmacology|November 22, 2002
In vitro human plasma leucine(5)-enkephalin degradation is inhibited by a select number of drugs with the phenothiazine molecule in their chemical structureAron D Mosnaim, Javier Puente, Rolando Saavedra, et al.
Headache|April 28, 2004
Inpatient treatment of headache: an evidence-based assessmentFrederick G Freitag, Al Lake, Richard Lipton, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Physician and Sportsmedicine|December 28, 2017
Treating Athletes Who Have Posttraumatic HeadachesSeymour Diamond
CNS Drugs|May 25, 2002
Practical approaches to migraine managementSeymour Diamond, Richard Wenzel
Postgraduate Medicine|July 15, 2016
Editor's MailSeymour Diamond, Charles B Fernandes, Arnold Potek
Headache|May 13, 2008
American headache through the decades: 1950 to 2008Seymour Solomon, Seymour Diamond, Ninan Mathew, et al.
Headache|November 29, 2007
Botulinum Toxin Type A in the treatment of chronic migraine without medication overuseFrederick G Freitag, Seymour Diamond, Merle Diamond, et al.
The Journal of Headache and Pain|January 16, 2007
Sumatriptan 6 mg subcutaneous as an effective migraine treatment in patients with cutaneous allodynia who historically fail to respond to oral triptansSeymour Diamond, Fred G Freitag, Alexander Feoktistov, et al.
Pharmacotherapy|May 28, 2004
Migraine headache misconceptions: barriers to effective careRichard Wenzel, Marcus Dortch, Roger Cady, et al.
Headache|June 24, 2008
Efficacy and tolerability of coadministration of rizatriptan and acetaminophen vs rizatriptan or acetaminophen alone for acute migraine treatmentFred Freitag, Merle Diamond, Seymour Diamond, et al.
Pharmacology|November 22, 2002
In vitro human plasma leucine(5)-enkephalin degradation is inhibited by a select number of drugs with the phenothiazine molecule in their chemical structureAron D Mosnaim, Javier Puente, Rolando Saavedra, et al.
Headache|April 28, 2004
Inpatient treatment of headache: an evidence-based assessmentFrederick G Freitag, Al Lake, Richard Lipton, et al.
Pageof 2